ISCG
iShares Morningstar Small-Cap Growth ETF
ISCG tracks a market-cap-weighted index of US small-cap growth stocks. The index selects stocks from 90-99.5% of market cap that fall into Morningstar's growth style categorization.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.0 B
ASSETS UNDER MGMT
6 bp
EXPENSES
Fund Basics
| Inception date | Jun 28, 2004 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| REGAL BELOIT CORP | 0.8 % |
| OKTA, INC. CLASS A | 0.8 % |
| GUARDANT HEALTH, INC. | 0.7 % |
| ROKU, INC. CLASS A | 0.6 % |
| STERLING CONSTRUCTION CO | 0.6 % |
| NANOMETRICS INC | 0.6 % |
| NEUROCRINE BIOSCIENCES INC | 0.5 % |
| ATLASSIAN CORP. CLASS A | 0.5 % |
| NUTANIX, INC. CLASS A | 0.5 % |
| NORDSON CORP | 0.5 % |
Constituent Breakdown
| Number of holdings | 953 |
| Herfindahl-Hirschman Index | 21 |
| Wgt avg mkt cap (mns) | $8,096 |
| Large cap (>$10bn) | 36.3% |
| Mid cap ($2-10bn) | 52.6% |
| Small cap (<$2bn) | 5.4% |
| Developed mkts. | 94.6% |
| Emerging mkts. | 0.1% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.4 % |
 |
CANADA | 0.7 % |
 |
AUSTRALIA | 0.5 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 12.9% | 22.9% | 13.8% | 13.1% | 4.5% | 10.1% | 9.0% | -30.1% |
| Dividend Yield | 0.3% | 0.8% | 0.9% | 0.9% | 0.8% | 0.7% | 0.6% | -5.1% |
| Total Returns | 13.2% | 23.7% | 14.7% | 13.9% | 5.3% | 10.9% | 9.7% | -35.2% | Ann. Volatility | 18.7% | 18.6% | 21.5% | 20.5% | 23.0% | 23.1% | 23.7% | 31.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.23 | 72% |
| MSCI EAFE | 0.88 | 55% |
| MSCI Emg Mkts | 0.55 | 51% |
Liquidity Measures
| Avg. volume (000) | 23 |
| ADV traded (mns) | $2 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.28% |
Technical Indicators
| 30d moving avg. (EMA) | $62.98 |
| Relative strength (RSI) | 51 |
| MACD/Signal | -0.20/-0.06 |
| Bollinger Bands (Upper/Lower) | $64.55/$61.83 |
| Short interest (% of AUM) | 0.9% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. ISCG |
Expenses vs. ISCG |
ALTAR Score™ vs. ISCG |
|---|---|---|---|---|
| ISCB | iShares Morningstar Small-Cap ETF | 60.5% | -2 bp | +2.4% |
| SMMD | iShares Russell 2500 ETF | 50.4% | +9 bp | +2.7% |
| VBK | Vanguard Small-Cap Growth ETF | 50.3% | +1 bp | -1.3% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 47.9% | +11 bp | +2.0% |
| DFAS | Dimensional U.S. Small Cap ETF | 44.3% | +20 bp | +2.6% |
| VB | Vanguard Small-Cap ETF | 44.3% | -1 bp | +2.3% |
| VXF | Vanguard Extended Market ETF | 43.4% | -1 bp | +1.0% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 41.9% | +1 bp | +2.4% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 40.7% | -2 bp | +2.8% |
| IWM | iShares Russell 2000 ETF | 39.1% | +13 bp | -0.3% |
Risk and Returns: ISCG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/9/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.2%
ALTAR SCORE™
16th
PERCENTILE
AVOID
ETFRC RATING
There are 1,402 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. ISCG's ALTAR Score™ is approximately -1.0 standard
deviations above the category average. This places ISCG in the 16th percentile
among funds in the category.
Sell-Side Consensus
$72.28
PRICE TARGET
+10.4%
UPSIDE